<?xml version="1.0" encoding="UTF-8"?>
<list list-type="bullet" id="list12-0020731420946590">
 <list-item>
  <p>The vaccine is effective. No antiviral therapy is available, but supportive treatment is relatively effective. Aedes Egypti control is effective but difficult.
   <sup>
    <xref rid="bibr55-0020731420946590" ref-type="bibr">55</xref>
   </sup>
  </p>
 </list-item>
 <list-item>
  <p>There is no human-to-human transmission. Epidemics are related to mosquitoes.</p>
 </list-item>
 <list-item>
  <p>Worldwide, there were 84,000–170,000 severe cases in 2013.</p>
 </list-item>
 <list-item>
  <p>CFR is 15%–50%.
   <sup>
    <xref rid="bibr56-0020731420946590" ref-type="bibr">56</xref>
   </sup>
  </p>
 </list-item>
 <list-item>
  <p>Mortality is 29,000–60,000 deaths per year.</p>
 </list-item>
 <list-item>
  <p>Yellow Fever shows no occupational concentration.</p>
 </list-item>
 <list-item>
  <p>The disease is exceptional in Europe. For 2017, European Union/European Economic Area countries reported 1 travel-related case of Yellow Fever. The case was reported by the Netherlands with exposure in Suriname.
   <sup>
    <xref rid="bibr57-0020731420946590" ref-type="bibr">57</xref>
   </sup>
  </p>
 </list-item>
</list>
